Pain News and Research

Latest Pain News and Research

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.

15 Jun 2011

Akela reports total consolidated revenues of $4.2 million for three months ended March 31, 2011

Akela Pharma, Inc., a drug development company with its lead product, Fentanyl TAIFUN, being developed for the treatment of breakthrough cancer pain and the company's wholly owned subsidiary, PharmaForm, a leading specialty contract service provider in the area of pharmaceutical dosage form development and manufacturing, today announced its financial results for the three months and year ended March 31, 2011.

15 Jun 2011

Abbott’s CREON receives FDA approval for infant-specific dose

Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.

14 Jun 2011

Boiron launches new natural and non-steroidal products for athletes to treat muscle pain

Boiron Canada launches Arnicare Sport, a brand new product designed for athletes, whether professional, amateur or recreational. Arnicare Sport makes physical activity pleasant by preventing and reducing cramps, aches and muscular fatigue.

14 Jun 2011

Orexo completes first OX27 pharmacokinetic trial against breakthrough pain in cancer

Orexo AB announces a successful outcome following completion of the first OX27 pharmacokinetic trial.

14 Jun 2011

Dengue virus circulating between monkeys, mosquitoes could emerge to cause human outbreaks

More than a thousand years ago, somewhere in Southeast Asia, a fateful meeting occurred between a mosquito-borne virus that infected mainly monkeys and a large, susceptible group of humans.

14 Jun 2011

Study explores age differences in barriers to cervical cancer screening attendance

Older women are too embarrassed to go for smear tests, and fear pain, while younger women are too busy, according to a Cancer Research UK study, published in BJOG: An International Journal of Obstetrics and Gynaecology today.

14 Jun 2011

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Alexion Pharmaceuticals, Inc. today announced the presentation of research that provides further insight into the clinical consequences of paroxysmal nocturnal hemoglobinuria (PNH), and positive impact of Soliris® (eculizumab) therapy on long-term outcomes.

13 Jun 2011

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine-clinicians, patient advocates, and regulators-to understand the causes behind avoidable mortality in legitimately treated patients.

13 Jun 2011

LA/hypnosis combination during surgery can aid healing process, reduce drug use and hospital stay time

Using a combination of hypnosis and local anaesthesia (LA) for certain types of surgery can aid the healing process and reduce drug use and time spent in hospital, anaesthesiologists have found. The combination could also help avoid cancer recurrence and metastases, according to new research to be presented today at the European Anaesthesiology Congress in Amsterdam.

13 Jun 2011

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Incyte Corporation announced today additional symptom improvement and quality of life (QoL) results from COMFORT-I, a randomized, double-blinded, placebo-controlled Phase III trial of Incyte's JAK1 and JAK2 inhibitor, ruxolitinib, in patients with myelofibrosis (MF).

13 Jun 2011

Only 35% of anaesthesiologists carry out cardiac output monitoring during high-risk surgery

Only 35% of anaesthesiologists are carrying out a simple procedure during high-risk surgery that can make a significant impact on how well patients recover from their operations, according to new research presented today at the European Anaesthesiology Congress in Amsterdam.

13 Jun 2011

Masimo receives GOLD 2011 Medical Design Excellence Award for Pronto-7 noninvasive hemoglobin

Masimo Corporation announced today that its Pronto-7 handheld noninvasive hemoglobin, arterial oxygen saturation (SpO2), pulse rate, and perfusion index spot-check testing device has received the GOLD 2011 Medical Design Excellence Award—the highest award given in the general hospital devices and therapeutic products category.

10 Jun 2011

Longer looks: Dr. Oz as patient; Utah puts Medicaid enrollees to work

As a federal judge considers whether to block the implementation of a recently-passed law that defunds Planned Parenthood of Indiana, more than 20,000 low-income patients are on the verge of losing their primary health care provider.

10 Jun 2011

Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease

Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott's investigational treatment for advanced Parkinson's disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in "off" time and an increase in "on" time without troublesome dyskinesias.

9 Jun 2011

Foundation for Peripheral Neuropathy to launch first ever national PN research registry

What starts as burning, numbness, pain, and/or tingling in the feet, or hands in some can turn into a debilitating condition. Peripheral Neuropathy (PN), one of the largest and most common neurodegenerative disorders, affects more than 20 million Americans of all races and ethnic backgrounds.

9 Jun 2011

Ameritox launches Rx Guardian CD, next-generation pain-medication monitoring solution

Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.

9 Jun 2011

Costs, insurance company regulations can make physical therapy a pain

Rebecca Neusteter fell off her bike and shattered her knee. ... She pays $140 out of pocket for each weekly physical therapy session. ... Scott Ward, the president of the American Physical Therapy Association says insurance company regulations and policies essentially force physical therapists to see as many patients as they can. ... Susan Pisano, a spokeswoman for America's Health Insurance Plans, says it's a dilemma caused by the rising cost of care in the U.S.

9 Jun 2011

Social, physical and spiritual activities can improve quality of life in older individuals

Small, healthy lifestyle changes and involvement in meaningful activities-going beyond just diet and exercise-are critical to healthy aging, according to a new USC study.

9 Jun 2011

Skin cell-derived CGRP-beta may cause chronic pain

A new study may explain why only 50% of patients experiencing chronic nerve pain achieve even partial relief from existing therapeutics. The study, published in the June 6 online version of the international research journal PAIN, reveals that certain types of chronic pain may be caused by signals from the skin itself, rather than damage to nerves within the skin, as previously thought.

9 Jun 2011

Pain News and Research

Latest Pain News and Research

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Akela reports total consolidated revenues of $4.2 million for three months ended March 31, 2011

Abbott’s CREON receives FDA approval for infant-specific dose

Boiron launches new natural and non-steroidal products for athletes to treat muscle pain

Orexo completes first OX27 pharmacokinetic trial against breakthrough pain in cancer

Dengue virus circulating between monkeys, mosquitoes could emerge to cause human outbreaks

Study explores age differences in barriers to cervical cancer screening attendance

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

LA/hypnosis combination during surgery can aid healing process, reduce drug use and hospital stay time

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Only 35% of anaesthesiologists carry out cardiac output monitoring during high-risk surgery

Masimo receives GOLD 2011 Medical Design Excellence Award for Pronto-7 noninvasive hemoglobin

Longer looks: Dr. Oz as patient; Utah puts Medicaid enrollees to work

Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease

Foundation for Peripheral Neuropathy to launch first ever national PN research registry

Ameritox launches Rx Guardian CD, next-generation pain-medication monitoring solution

Costs, insurance company regulations can make physical therapy a pain

Social, physical and spiritual activities can improve quality of life in older individuals

Skin cell-derived CGRP-beta may cause chronic pain

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in